Is combined estrogen/progestogen hormone therapy worth the risk?

Climacteric. 2003 Sep;6(3):177-9.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Breast Neoplasms / chemically induced*
  • Breast Neoplasms / epidemiology
  • Drug Therapy, Combination
  • Estrogen Replacement Therapy / adverse effects*
  • Female
  • Humans
  • Middle Aged
  • Progestins / administration & dosage
  • Progestins / adverse effects*
  • Risk Factors

Substances

  • Progestins